Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 11%
Sell 11%
Strong Sell 0%

Bulls say

CareTrust REIT has significantly expanded its structured finance portfolio, growing from $15 million in early 2022 to $871 million, which enhances its operator relationships and diversifies portfolio yields. The company has outperformed industry averages, achieving the highest Funds From Operations (FFO) growth rate while maintaining the lowest leverage profile among its peers, positioning it well for continued growth. Analysts anticipate embedded Funds Available for Distribution (FAD) growth of 10% by 2026, coupled with expectations for another strong year of accretive acquisitions, supporting a favorable long-term outlook for the company's market performance.

Bears say

CareTrust REIT's stock outlook is negatively impacted by increasing competition that may drive up property prices, thereby adversely affecting the company’s profitability. Additionally, potential illiquidity in capital markets could threaten cash investments and overall valuations, further straining financial performance. Furthermore, the company faces tenant-related challenges that could hinder earnings growth, while its lease yield of 8.1% falls significantly short of the approximately 10% yields seen with peers, exacerbating concerns over investment returns.

CareTrust REIT (CTRE) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 11% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 9 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $40.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $40.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.